December Issue: Can Contralateral Template Dissection be Avoided in Post-chemotherapy Retroperitoneal #LymphNodeDissection for Non-seminomatous #GermCellTumors ? @gurushankari_b @anandoncologist rdcu.be/eTl2w @SyedAAhmad5 @SocSurgOnc

Single-institution retrospective analysis shows that segmentectomy was associated with ⬇️ lymph node sampling --> ⬇️ detection of occult nodal metastasis in N1 lymph nodes 🔗:pubmed.ncbi.nlm.nih.gov/4081… @yosuzukimd @JTOonline #NSCLC #Segmentectomy #LymphNodeDissection

External validation of nomograms for predicting lymph node invasion (LNI) in prostate cancer patients with negative PSMA PET-CT. What did we find? The Briganti 2023 nomogram is the most accurate! 📊✅ 🔍 Why does it matter? Extended pelvic lymph node dissection (ePLND) is the gold standard for staging but comes with risks. With PSMA PET-CT revolutionizing imaging, we need better predictive tools to avoid unnecessary procedures. 📌 Key Findings: •Among 282 patients, 13% had LNI despite negative PSMA PET-CT. •The Briganti 2023 nomogram outperformed others (C-index: 77% vs. MSKCC 64%, Briganti 2017 69%, Amsterdam-Brisbane-Sydney 64%). •Using a 5% risk cutoff would spare 47% of ePLND procedures while missing only 3.8% of LNI cases! 🚫🔬 ⚖️ Clinical Impact: •Improves decision-making: More precise risk stratification means fewer unnecessary surgeries. •Saves patients from complications: ePLND has side effects; avoiding it when possible is crucial. •Guides personalized treatment: Selecting the right patients for ePLND enhances care quality. 👨‍⚕️ Takeaway: The Briganti 2023 nomogram should be the go-to tool for predicting LNI in prostate cancer patients with negative PSMA PET-CT! 📈 🔗 Read the full study here: sciencedirect.com/science/ar… #ProstateCancer #Urology #PSMAPET #LymphNodeDissection #Nomogram

December Issue: Omission of Axillary #LymphNodeDissection in Patients with Residual Nodal Disease After #NeoadjuvantChemotherapy @JNLimbergMD @chibaAkiko @RosenbergerMd rdcu.be/d4kX2 @drsergioaguilar @SyedAAhmad5

#AudioVisualAbstract : Omission of Completion #LymphNodeDissection in #SentinelNodeBiopsy Positive Head and Neck #CutaneousMelanoma Patients rdcu.be/dyyH0

Check it out ! All about LND in UTUC . 📚💡 Perfect resource for anyone seeking a comprehensive update on this vital topic. 🩺👏 rdcu.be/dnVZX📰 🚀 #UTUC #LymphNodeDissection

#VisualAbstract : Oncological Outcome After #LymphNodeDissection for Cutaneous #SquamousCellCarcinoma rdcu.be/dl8ye

#VisualAbstract : Axillary #LymphNodeDissection is Associated with Improved Survival Among Men with Invasive #BreastCancer and #SentinelNode Metastasis rdcu.be/dlWqT

#VisualAbstract : Learning Curve of Robot-Assisted #LymphNodeDissection of the Left Recurrent #LaryngealNerve : A Retrospective Study of 417 Patients rdcu.be/diWAj

#VisualAbstract : Radiation, #LymphNodeDissection , or Both: Management of Lymph Node #Micrometastases from #MerkelCellCarcinoma rdcu.be/digw8

#VisualAbstract : Adding #InductionChemotherapy Before #Chemoradiotherapy with Total #MesorectalExcision and Selective Lateral #LymphNodeDissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low #RectalCancer May Improve #OncologicOutcomes rdcu.be/dhToK

AUGUST ISSUE: Oncological Outcome After #LymphNodeDissection for #CutaneousSquamousCellCarcinoma. rdcu.be/dhJXu @SocSurgOnc

#VisualAbstract : Delayed Sentinel #LymphNodeDissection in Patients with a Preoperative Diagnosis of #DuctalCancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (#SPIO ) Nanoparticles: The SentiNot Study @KarakatsanisA rdcu.be/dgilB

‘Fluorescence guided lymph node dissection in gastric cancer: new standard?’ - Silvia Quaresima #gasriccancer #lymphnodedissection #fluorescence #icg #eaes2023 #diagnosticgreen

NOVEMBER ISSUE: Impact of #LymphNodeDissection on Survival and Tumor Recurrence for Patients with Resected cT1-2N0 #SmallCellLungCancer rdcu.be/cYqGB @McMastersKelly @SocSurgOnc

Comparison of Standard D2 and Limited #LymphNodeDissection in Elderly Patients with Advanced #GastricCancer rdcu.be/cPkdz #VisualAbstract @McMastersKelly

#AdjuvantTherapy for Stage III #Melanoma Without Immediate Completion #LymphNodeDissection . @AnaGleisner rdcu.be/cGm7P #VisualAbstract @McMastersKelly

JANUARY ISSUE: Stepwise Limited Axillary #LymphNodeDissection Based on #LymphaticDrainage from the Breast to Decrease #BreastCancer-RelatedLymphedema: A Randomized Controlled Trial.rdcu.be/cESOm @McMastersKelly @SocSurgOnc

Surveillance of #SentinelNodePositive #Melanoma Patients Who Receive #AdjuvantTherapy Without Undergoing Completion #LymphNodeDissection . @KristyBroman @jzager99 rdcu.be/cDdxm #VisualAbstract @McMastersKelly

NOVEMBER ISSUE: Surveillance of #SentinelNode-PositiveMelanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion #LymphNodeDissection. #melanoma rdcu.be/cAYBz @McMastersKelly @SocSurgOnc